Our technology is a breakthrough in the diagnosis and treatment of psychiatric and neurological disorders.
NeuralDx's EVestG can objectively diagnose psychiatric or neurological disorder within moments of testing. With EVestG, a diagnosis is possible at the first visit to the clinician’s office.
The product of nearly a decade of research and development, NeuralDx represents a historic change for global health. Existing diagnostic methodology for psychiatric and neurological disorders is subjective and lacks the accuracy and consistency required for the management of such a massive, global health issue. This absence of effective diagnostic technology causes delays that contribute significantly to the $2 trillion dollars per year spent managing the impact of these disorders.